FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

410951004: Ibritumomab tiuxetan (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2007. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2466402013 Ibritumomab tiuxetan (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2472598018 Ibritumomab tiuxetan en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2466402013 Ibritumomab tiuxetan (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2466402013 Ibritumomab tiuxetan (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2472598018 Ibritumomab tiuxetan en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2472598018 Ibritumomab tiuxetan en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Ibritumomab tiuxetan Is a Product containing ibritumomab tiuxetan (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Ibritumomab tiuxetan The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Monoclonal antibody false Inferred relationship Existential restriction modifier (core metadata concept)
    Ibritumomab tiuxetan The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Ibritumomab tiuxetan (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Ibritumomab tiuxetan The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Antineoplastic agent (substance) false Inferred relationship Existential restriction modifier (core metadata concept)

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Ibritumomab tiuxetan 1.6mg/mL radiopharmaceutical infusion kit Is a False Ibritumomab tiuxetan Inferred relationship Existential restriction modifier (core metadata concept)
    Ibritumomab tiuxetan 3.2mg injection solution 2mL vial Is a False Ibritumomab tiuxetan Inferred relationship Existential restriction modifier (core metadata concept)

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    Description inactivation indicator reference set

    GB English

    US English

    SAME AS association reference set (foundation metadata concept)

    Back to Start